Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-25wd4 Total loading time: 0 Render date: 2024-04-27T15:20:51.443Z Has data issue: false hasContentIssue false

4 - Rapid tranquillisation

from Part I - Therapeutic interventions

Published online by Cambridge University Press:  22 August 2009

M. Dominic Beer
Affiliation:
Oxleas NHS Foundation Trust
Stephen M. Pereira
Affiliation:
Goodmayes Hospital, Essex
Carol Paton
Affiliation:
Oxleas NHS Foundation Trust
Caroline L. Holmes
Affiliation:
Consultant, Forensic Psychiatrist, The Essex Forensic Mental Health Service, Runwell Hospital, Wickford, Essex, UK
Helen Simmons
Affiliation:
Consultant Psychiatrist
Get access

Summary

Introduction

Violence is a continuing problem in both inpatient and outpatient psychiatry. Past authors have concluded that violence is no more likely in the psychiatric population than in the general population, but there is an increasing consensus that people with psychotic illnesses are more likely to exhibit violence in the community (Mullen 1988; Monahan 1992; Mulvey 1994; Swanson et al. 1996).

Violence in the psychiatric setting may be acute, as seen in a severely disturbed patient with paranoid schizophrenia or mania, or ongoing, as seen inpatients who are chronically psychotic or those with personality disorders. In the UK, the acutely violent patient should ideally be treated in a Psychiatric Intensive Care Unit (PICU) until more settled. In the context of acute violence on the ward, the primary concern is to ensure the safety of patients and staff and any intervention should be the minimum required to calm the patient. However, in many cases medication is needed.

Rapid tranquillisation (RT) has been defined as ‘the use of psychotropic medication to control agitated, threatening or destructive psychotic behaviour’ (Ellison et al. 1989). The NICE guidelines describe RT as drug treatment used to achieve a, ‘reduction in agitation or aggression without sedation’ (National Institute for Clinical Excellence; NICE 2005).

It should not be confused with rapid neuroleptisation (RN), which entails giving high loading doses of neuroleptics to achieve an early remission. There is no evidence that RN offers any therapeutic advantages over the use of standard doses while side-effects are significantly greater.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alexander, J, Tharyan, P, Adams, C, John, T, Mol, C, Philip, J. 2004 Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting. Pragmatic randomised trial of intramuscular lorazepam v. haloperidol plus promethazine. Br J Psychiatry 185: 63–69Google Scholar
Arana, GW, Ornsteen, ML, Kanter, FF, Friedman, HL, Greenblatt, DJ, Shader, SI. 1986 The use of benzodiazepines for psychiatric disorders: a literature review and preliminary clinical findings. Psychopharmacol Bull 22(1): 77–87Google Scholar
Baastrup, PC, Alhfors, UG, Bjerkenstedt, Let al. 1993 A controlled Nordic multicentre study of zuclopenthixol acetate in oil solution, haloperidol and zuclopenthixol in the treatment of acute psychosis. Acta Psychiatr Scand 87: 48–58Google Scholar
Baker, RW, Kinon, BJ, Maguire, GA, Liu, H, Hill, AL. 2003 Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation. J Clin Psychopharmacol 23(4): 42–348Google Scholar
Bell, MD, Rao, VJ, Weitli, C, Rodriguez, RN. 1992 Positional asphyxia in adults: 30 cases. Am J Forensic Med Pathol 13: 101–107Google Scholar
Bick, PA, Hannah, AL. 1986 Intramuscular lorazepam to restrain violent patients. Lancet 1(8474):206Google Scholar
Binder, RL, McCoy, SM. 1985 Patients' attitudes towards placement in seclusion. J Nervous Mental Dis 173: 273–286Google Scholar
Bourdouxhe, S, Mirel, J, Denys, W, Bobon, D. 1987 L'acetate de zuclopenthixol et l'haloperidol dans la psychose aigue. Acta Psychiatr Belg 87: 236–244Google Scholar
Breier, A, Meehan, K, Birkett, Met al. 2002 A double-blind, placebo-controlled dose-response comparison of intramusular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Arch Gen Psychiatry 59: 441–448Google Scholar
Brook, S, Lucey, JV, Gunn, KP for the Ziprasidone, IM Study Group. 2000 Intramuscular ziprasadone compared with intramuscular haloperidol in the treatment of acute psychosis. J Clin Psychiatry 61(12): 933–941Google Scholar
Bursten, B. 1975 Using mechanical restraints on acutely disturbed psychiatric patients. Hosp Community Psychiatry 30: 48–55Google Scholar
Charlton, JE. 1995 Monitoring and supplemental oxygen during endoscopy. Br Med J 310: 886–888Google Scholar
Chouinard, G, Safadi, G, Beauclair, L. 1994 A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation. J Psychopharmacol 14(6): 126–129Google Scholar
Corrigan, PW, Yodufsky, SC, Silver, JM. 1993 Pharmacological and behavioural treatments for aggressive psychiatric inpatients. Hosp Community Psychiatry 44: 125–133Google Scholar
Coutinho, E, Fenton, M, Campbell, C, David, A. 1997 Details of studies of zuclopenthixol are needed (letter). Br Med J 315: 884Google Scholar
Coutinho, E, Fenton, M, Adams, C, Campbell, C. 2000 Zuclopenthixol acetate in psychiatric emergencies: looking for evidence from clinical trials. Schizophr Res 46: 111–118Google Scholar
Cunnane, JG. 1994 Drug management of disturbed behaviour by psychiatrists. Psychiatr Bull 18: 138–139Google Scholar
David, SR, Beasley, CM Jr, Alaka, K. 2002 QTc intervals during treatment with olanzapine in acutely agitated patients. Schizophr Res Suppl 53: 164Google Scholar
Fuente, JR, Rosenbaum, AH, Martin, HRNiven, RG. 1980 Lorazepam-related withdrawal seizures. Mayo Clin Proc 55(3): 190–192Google Scholar
Department of Health and Welsh Office. 1993 Code of Practice – Mental Health Act 1983. London: HMSO
Dubin, WR. 1988 Rapid tranquillization: antipsychotics or benzodiazepines?J Clin Psychiatry Suppl 49: 5–12Google Scholar
Dubin, WR, Weiss, KJ. 1986 Rapid tranquillization: a comparison of thiothixene with loxapine. J Clin Psychiatry 47(6): 294–297Google Scholar
Ellison, J, Hughes, D, White, K. 1989 An emergency psychiatry update. Hosp Community Psychiatry 40(3): 250–260Google Scholar
Fitzgerald, P. 1999 Long-acting antipsychotic medication, restraint and treatment in the management of acute psychosis. Aust N Z J Psychiatry 33: 660–666Google Scholar
Freinhar, JP, Alvarez, WH. 1985 Use of clonazepam in two cases of acute mania. J Clin Psychiatry 46(1): 29–30Google Scholar
Glassman, AH, Bigger, JT Jr. 2001 Antipsychotic drugs: prolonged QTc interval, torsades de pointes and sudden death. Am J Psychiatry 158: 1774–1782Google Scholar
Goldberg, RJ, Dubin, WR, Fogel, BS. 1989 Review. Behavioural emergencies, assessment of psychopharmacologic management. Clin Neuropharmacol 12(4): 233–248Google Scholar
Goldney, RD, Spence, ND, Bowes, JA. 1986 The safe use of high-dose neuroleptics in a psychiatric intensive care unit. Aust N Z J Psychiatry 20: 370–375Google Scholar
Gutheil, TG. 1985 Rogers v. Commissioner. Denouement of an important right-to-refuse-treatment case. Am J Psychiatry 142(2): 213–216Google Scholar
Henderson, C, Flood, C, Leese, M, Thornicroft, G, Sutherby, K, Szmukler, G. 2004 Effect of joint crisis plans on use of compulsory treatment in psychiatry: single blind randomised controlled trial. Br Med J 329:136–138Google Scholar
Huyse, F, Schijndel, RS. 1988 Haloperidol and cardiac arrest. Lancet : 568–569Google Scholar
Hyde, CE, Harrower-Wilson, C. 1994 Psychiatric intensive care: principles and problems. Hosp UpdateMay: 287–295Google Scholar
Hyde, CE, Harrower-Wilson, C, Morris, J. 1998 Violence, dissatisfaction and rapid tranquillisation in psychiatric intensive care. Psychiatr Bull 22: 477–480Google Scholar
Jacobs, D. 1983 Evaluation and management of the violent patient in emergency settings. Psychiatr Clin North Am 6(2): 259–269Google Scholar
Jones, R. ed. 1996 Mental Health Act Manual, 5th edn. London: Sweet & Maxwell
Jones, SE. 1995 Getting the balance right. Professional Nurse368–373Google Scholar
Kane, JM. 1977 Treatment of schizophrenia. Schizophr Bull 13(1): 133–156Google Scholar
Karagianis, JL, Dawe, IC, Thakur, A, Begin, S, Raskin, J, Roychowdhury, SM. 2001 Rapid tranquillization with olanzapine in acute psychosis: a case series. J Clin Psychiatry 62(2): 12–16Google Scholar
Kerr, IB, Taylor, D. 1997 Acute disturbed or violent behaviour: principles of treatment. J Psychopharmol 11(3): 271–277Google Scholar
Kidd, B, Stark, C (eds). 1995 Management of Violence and Aggression in Health Care. London: Gaskell
Konikoff, F, Kuritzky, A, Jerushalmi, Y, Theodor, E. 1984 Neuroleptic malignant syndrome induced by a single injection of haloperidol [letter]. Br Med J 289: 1228–1229Google Scholar
Leadbetter D, Paterson B. 1995 De-escalating aggressive behaviour. In: Kidd, B, Stark, C (eds) Management of Violence and Aggression in Health Care. London: Gaskell, pp. 49–84
Lerner, Y, Lwow, E, Levitin, A, Belmaker, RH. 1979 Acute high-dose parenteral haloperidol treatment of psychosis. Am J Psychiatry 136: 1061–1064Google Scholar
Lesem, MD, Zajecka, JM, Swift, RH, Reeves, KR, Harrigan, EP. 2001 Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients. J Clin Psychiatry 62(1): 12–18Google Scholar
Man, PL, Chen, CH. 1973 Rapid tranquillization of acutely psychotic patients with intramuscular haloperidol and chlorpromazine. Psychsomatics 14: 59–63Google Scholar
Mannion, L, Sloan, D, Connolly, L. 1997 Rapid tranquillisation: are we getting it right?Psychiatr Bull 21(7): 411–413Google Scholar
Mattson, MR, Sacks, MH. 1978 Seclusion: uses and complications. Am J Psychiatry 135: 1210–1213Google Scholar
McAllister-Williams, R, Ferrier, IN. 2001 Rapid tranquilllisation: time for a reappraisal of options for parenteral therapy. Br J Psychiatry 179: 485–489Google Scholar
McLaren, S, Browne, FWA, Taylor, PJ. 1990 A study of psychotropic medication given as required in a regional secure unit. Br J Psychiatry 156: 732–735Google Scholar
Meehan, K, Zhang, F, David, Set al. 2001 A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. J Clin Psychopharmacol 21(4): 389–397Google Scholar
Mendoza, R, Djenderedjian, AH, Adams, J, Ananth, J. 1987 Midazolam in acute psychotic patients with hyperarousal. J Clin Psychiatry 48(7): 291–292Google Scholar
Modell, JG. 1986 Further experience and observations with lorazepam in the management of behavioural agitation. J Clin Psychopharmacol 6(6): 85–387Google Scholar
Moldin, SO. 1985 The effect of Rogers on forensic, emergency psychiatry. Am J Psychiatry 142(12): 1521–1522Google Scholar
Monahan, J. 1992 Mental disorder and violent behaviour. Am PsychologistApril: 511–521Google Scholar
Mullen, P. 1988 Violence and mental disorder. Br J Hosp Med 40: 460–463Google Scholar
Mullen, R, Caan, AW, Smith, S. 1994 Perception of equivalent doses of neuroleptic drugs. Psychiatr Bull 18(6) 335–337Google Scholar
Mulvey, EP. 1994 Assessing the evidence of a link between mental illness and violence. Hosp Community Psychiatry 45(7): 663–668Google Scholar
National Institute for Clinical Excellence. 2002 Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. Clinical Guideline1. www.nice.org.uk
National Institute for Clinical Excellence. 2003 Guidance on the Use of Electroconvulsive Therapy. Technology appraisal 59. www.nice.org.uk
National Institute for Clinical Excellence. 2005 Violence. The Short Term Management of Disturbed/Violent Behaviour in Inpatient Psychiatric Settings and Emergency Departments. Clinical Guideline 25. www.nice.org.uk
National Institute for Mental Health in England. Mental Health Policy Implementation Guide: Developing Positive Practice to Support the Safe and Therapeutic Management of Aggression and Violence in Mental Health In-patent Settings. 2004. London: Department of Health
Norfolk, Suffolk and Cambridgeshire Strategic Health Authority. 2003 Independent Inquiry into the Death of David Bennett. Cambridge: Norfolk, Suffolk and Cambridgeshire Strategic Health Authority. Available online at www.irr.org.uk/pdf/bennett_inquiry.pdf
Papageorgiou, A, King, M, Janmohamed, A, Davidson, O, Dawson, J. 2002 Advance directives for patients compulsorily admitted to hospital with serious mental illness. Randomised controlled trial. Br J Psychiatry 181: 513–519Google Scholar
Pilowsky, LS, Ring, H, Shine, PJ, Battersby, M, Lader, M. 1992 Rapid tranquillisation. A survey of emergency prescribing in a general psychiatric hospital. Br J Psychiatry 160: 831–834Google Scholar
Plutchik, R, Karasu, TB, Conte, HR, Siegal, B, Jerret, I. 1978 Toward a rationale for the seclusion process. J Nervous Mental Dis 166(8): 571–579Google Scholar
Quenstedt, M, Ramsey, R, Bernadette, M. 1992 Rapid tranquillisation. Br J Psychiatry 161: 573Google Scholar
Ray, WA, Meredith, S, Thapa, PB, Meador, KG, Hall, K, Murray, KT. 2001 Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry 58: 1161–1167Google Scholar
Reilly, JG, Ayis, SA, Ferrier, IN, Jones, SJ, Thomas, SHL. 2000 QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 355: 1048–1052Google Scholar
Rosen, H, DiGiacomo, JN. 1978 The role of physical restraint in the treatment of psychiatric illness. J Clin Psychiatry 39: 228–232Google Scholar
Royal College of Psychiatrists. 1998 Management of Imminent Violence. Clinical Practice Guidelines to Support Mental Health Services. Occasional Paper OP41 March. London: Royal College of Psychiatrists
Russell, D, Hodgkinson, P, Hillis, T. 1986 Time out: are disturbed patients secluded for purely clinical reasons?Nurs Times 82(9): 47–49Google Scholar
Salzman, C. 1988 Use of benzodiazepines to control disruptive behaviour inpatients. J Clin Psychiatry 49 (12) [suppl]: 13–15Google Scholar
Salzman, C, Soloman, D, Miyawaki, Eet al. 1991 Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behaviour. J Clin Psychiatry 52(4): 177–180Google Scholar
Sheard, MH. 1988 Review: clinical pharmacology of aggressive behaviourClin Pharmacol 11: 483–492Google Scholar
Shugar, G, Rehaluk, R. 1990 Continuous observation in-patients: a critical evaluation. Compr Psychiatry 31(1): 48–55Google Scholar
Silva, E. 1999 Rapid tranquillisation in isolated units, i.m. medication preferable to i.v. J Psychopharmacol 13: 200–201Google Scholar
Simpson, D, Anderson, I. 1996 Rapid tranquillisation: a questionnaire survey of practice. Psychiatr Bull 20(3): 149–152Google Scholar
Sims, J. 1996 Making sense of pulse oximetry and oxygen dissociation curve. Nursing Times 92(1): 34–35Google Scholar
Soliday, SM. 1985 A comparison of patient and staff attitudes towards seclusion. J Nervous Mental Dis 173: 273–286Google Scholar
Swanson, JW, Borum, R, Swatrz, MS, Monahan, J. 1996 Psychotic symptoms and disorders and the risk of violent behaviour in the community. Criminal Behav Mental Health 6: 309–329Google Scholar
Taylor, D, Paton, C, Kerwin, R. 2005 The South London and Maudsley NHS Trust Prescribing Guidelines, 8th edn London:Martin Dunitz
Taylor, DM. 2003 Antipsychotics and QT prolongation. Acta Psychiatr Scand 107: 85–95Google Scholar
Taylor, P, Fleminger, JJ. 1980 ECT and schizophrenia. Lancet, 1(8183): 1380–1382Google Scholar
Taylor PJ. 1993 Mental illness and violence. In: Taylor, PJ (ed) Violence in Society. London: Royal College of Physicians
Thompson, C. 1994 Consensus statement: the use of high-dose antipsychotic medication. Br J Psychiatry 164: 448–458Google Scholar
Tuason, VB. 1986 A comparison of parenteral loxapine and haloperidol in hostile and aggressive acutely schizophrenic patients. J Clin Psychiatry 47(3): 126–129Google Scholar
Wadeson, H, Carpenter, WT. 1976 Impact of the seclusion room experience. J Nervous Mental Dis 163: 318–328Google Scholar
Welch, R, Chue, P. 2000 Antipsychotic agents and QT changes. Rev Psychiatr Neurosci 25(2): 154–160Google Scholar
Wilson, WH, Weiler, SJ. 1984 Case report of phenothiazine induced torsade de points. Am J Psychol 141: 1265–1266Google Scholar
Wright, P, Birkett, M, David, Set al. 2001 Double-blind placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. Am J Psychiatry 158(7): 1149–1151Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×